Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia
- 1 May 1994
- journal article
- Published by Elsevier in The Lancet
- Vol. 343 (8907) , 1188-1190
- https://doi.org/10.1016/s0140-6736(94)92400-7
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Intravenous mercaptopurine: life begins at 40.Journal of Clinical Oncology, 1993
- Studies Strategies and DesignJournal of Pediatric Hematology/Oncology, 1993
- High-performance liquid chromatographic assay of the methyl and nucleotide metabolites of 6-mercaptopurine: quantitation of red blood cell 6-thioguanine nucleotide, 6-thioinosinic acid and 6-methylmercaptopurine metabolites in a single sampleJournal of Chromatography B: Biomedical Sciences and Applications, 1992
- Maintenance chemotherapy and cure of childhood acute lymphoblastic leukaemiaThe Lancet, 1991
- Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (Report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood)British Journal of Haematology, 1991
- Pharmacokinetics of Mercaptopurine in Children with Acute Lymphocytic LeukemiaNew England Journal of Medicine, 1990
- Systemic Exposure to Mercaptopurine as a Prognostic Factor in Acute Lymphocytic Leukemia in ChildrenNew England Journal of Medicine, 1990
- Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemiaThe Lancet, 1990
- Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia.Journal of Clinical Oncology, 1989
- ARE CHILDREN WITH LYMPHOBLASTIC LEUKAEMIA GIVEN ENOUGH 6-MERCAPTOPURINE?The Lancet, 1987